Viewing Study NCT02531633


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2026-03-02 @ 10:21 PM
Study NCT ID: NCT02531633
Status: TERMINATED
Last Update Posted: 2019-07-31
First Post: 2015-07-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10-16
Start Date Type: ACTUAL
Primary Completion Date: 2018-03-21
Primary Completion Date Type: ACTUAL
Completion Date: 2018-03-21
Completion Date Type: ACTUAL
First Submit Date: 2015-07-06
First Submit QC Date: None
Study First Post Date: 2015-08-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-03-21
Results First Submit QC Date: None
Results First Post Date: 2019-05-31
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-07-18
Last Update Post Date: 2019-07-31
Last Update Post Date Type: ACTUAL